• 1
    Moreno R, Berenguer M. Post-liver transplantation medical complications. Ann Hepatol 2006; 5: 77.
  • 2
    Burra P, Mioni D, Cecchetto A, et al. Histological features after liver transplantation in alcoholic cirrhosis. J Hepatol 2001; 34: 716.
  • 3
    Tang H, Bolton R, Hubscher S, Gunson B, Neuberger J. Patterns of alcohol consumption after liver transplantation. Gut 1998; 43: 140.
  • 4
    Ong J, Younossi ZM, Reddy V, et al. Cryptogenic cirrhosis and post-transplantation non-alcoholic fatty liver disease. Liver Transpl 2001; 7: 797.
  • 5
    Gane EJ, Portmann BC, Naoumov NV, et al. Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med 1996; 334: 815.
  • 6
    Feray C, Caccamo L, Alexander GJ, et al. European collaborative study on factors influencing outcome after liver transplantation for hepatitis C. European Concerted Action on Viral Hepatitis (EUROHEP) Group. Gastroenterology 1999; 117: 619.
  • 7
    Wali MH, Heydtmann M, Harrison RF, Gunson B, Mutimer D. Outcome of liver transplantation for patients infected by hepatitis C, including those infected by genotype 4. Liver Transpl 2003; 9: 796.
  • 8
    Charlton M, Kasparova P, Weston S, et al. Frequency of non-alcoholic steatohepatitis as a cause of advanced liver disease. Liver Transpl 2001; 7: 608.
  • 9
    Bernal W, Wendon J, Rela M, et al. Use and outcome of liver transplantation in acetaminophen-induced acute liver failure. Hepatology 1998; 27: 1050.
  • 10
    Neuberger J, Gunson B, Hubscher S, Nightingale P. Immunosuppression affects the rate of recurrent primary biliary cirrhosis after liver transplantation. Liver Transpl 2004; 10: 488.
  • 11
    Vera A, Moledina S, Gunson B, et al. Risk factors for recurrence of primary sclerosing cholangitis of liver allograft. Lancet 2002; 360: 1943.
  • 12
    Graziadei IW. Recurrence of primary sclerosing cholangitis after liver transplantation. Liver Transpl 2002; 8: 575.
  • 13
    Milkiewicz P, Hubscher SG, Skiba G, Hathaway M, Elias E. Recurrence of autoimmune hepatitis after liver transplantation. Transplantation 1999; 68: 253.
  • 14
    Gautam M, Cheruvattath R, Balan V. Recurrence of autoimmune liver disease after liver transplantation: a systematic review. Liver Transpl 2006; 12: 1813.
  • 15
    Belle S, Beringer K, Detre K. Liver transplantation for alcoholic liver disease in the United States. Liver Transpl Surg 1997; 3: 212.
  • 16
    Neuberger J, Tang H. Relapse after transplantation: european studies. Liver Transpl Surg 1997; 3: 275.
  • 17
    Berlakovich GA. Wasting your organ with your lifestyle and receiving a new one? Ann Transplant 2005; 10: 38.
  • 18
    Keeffe E.B. Assessment of the alcoholic patient for liver transplantation: comorbidity, outcome and recidivism. Liver Transpl and Surg 1996; 2(Suppl. 1): 12.
  • 19
    Perry I, Neuberger J. Immunosuppression: towards a logical approach in liver transplantation. Clin Exp Immunol 2005; 139: 2.
  • 20
    Poonawala A, Nair SP, Thuluvath PJ. Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case–control study. Hepatology 2000; 32: 689.
  • 21
    Markowitz JS, Martin P, Conrad AJ, et al. Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin. Hepatology 1998; 28: 585.
  • 22
    Marzano A, Salizzoni M, Debemardi-Venon W, et al. Prevention of hepatits B recurrence after liver transplantation in cirrhostic patients treated with lamivudine and passive immunoprophylaxis. J Hepatol 2001; 34: 903.
  • 23
    Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334: 693.
  • 24
    Bizollon T, Ahmed SN, Radenne S, et al. Long term histological improvement and clearance of intrahepatic hepatitis C virus RNA following sustained response to interferon-ribavirin combination therapy in liver transplanted patients with hepatitis c virus recurrence. Gut 2003; 52: 283.
  • 25
    Charatcharoenwitthaya P, Pimentel S, Talwalkar JA, et al. Long-term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation. Liver Transpl 2007; 13: 1236.
  • 26
    Georgiou G, Webb K, Griggs K, Copello A, Neuberger J, Day E. First report of a psychosocial intervention for patients with alcohol-related liver disease undergoing liver transplantation. Liver Transpl 2003; 9: 772.
  • 27
    Mackie J, Groves K, Hoyle A, et al. Orthotopic liver transplantation for alcoholic liver disease: a retrospective analysis of survival, recidivism, and risk factors predisposing to recidivism. Liver Transpl 2001; 7: 418.
  • 28
    Pageaux G-P, Bismuth M, Perney P, et al. Alcohol relapse after liver transplantation for alcoholic liver disease: does it matter? J Hepatol 2003; 38: 629.